| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.77 | 7e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |